Pharmacometric model informed drug development in infectious diseases
-
Chair(s):
Joe Standing
Professor of Pharmacometrics,University College London, London, United Kingdom -
Session description:
Sponsored by the ISoP Clinical Special Interest Group
Role of pharmacometric modelling in drug development for infectious diseases
Dr Patrick Smith
Certara Ltd
Leveraging viral dynamic models in antiviral developmentProf. France Mentre
Professor of Pharmacometrics and Biostatistics, INSERM, Paris, FranceOral communication speaker - to be confirmed in 2022.
Beating malaria with pharmacometrics
Dr Jeff Barrett
Bill & Melinda Gates Medical Research Institute, The United States of America,Pharmacometrics of antiviral dynamics in SARS-CoV-2
Dr Silke Gastine
University College London United Kingdom, London, United Kingdom -
Sponsored by:
Speakers
-
Dr Jeff BarrettBill & Melinda Gates Medical Research Instutute The United States of America, Cambridge, The United States of America
-
Dr Patrick Smith
Certara Ltd
-
Dr Silke GastineUniversity College London, London, United Kingdom
-
Professor France MentreProfessor of Pharmacometrics and Biostatistics, INSERM, Paris, France
Leave A Comment